PerkinElmer pays premium to cut M&A funding costs
US health products and services company PerkinElmer priced a €300m corporate bond this week, nearly two years after its debut in the currency. The deal saw good demand as the company paid a spread of 60bp over mid-swaps for the three year notes.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: